Detalles de la búsqueda
1.
Evaluation of Miracle Mouthwash plus Hydrocortisone Versus Prednisolone Mouth Rinses as Prophylaxis for Everolimus-Associated Stomatitis: A Randomized Phase II Study.
Oncologist
; 24(9): 1153-1158, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833486
2.
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
Breast Cancer Res Treat
; 126(1): 101-8, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21188632
3.
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 118(2): 361-7, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19459042
4.
Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients.
NPJ Breast Cancer
; 5: 36, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667338
5.
Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
Cancer Med
; 7(6): 2288-2298, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29582557
6.
Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling.
BMC Res Notes
; 6: 507, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24304724
7.
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
J Clin Oncol
; 27(8): 1177-83, 2009 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-19204201
8.
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
J Clin Oncol
; 24(34): 5381-7, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17135639
Resultados
1 -
8
de 8
1
Próxima >
>>